E.V. Mahiliavets
Abstract. Non-cirrhotic causes of the development of portal hypertension make upabout 10%. The factors leading to its development are the development of thrombosis in the portal vein system, occlusion due to pancreatitis, pancreatic tumors, and other causes. Acute bleeding from esophageal varices is a formidable complication of portal hypertension, regardless of its etiology. The tactics of treatment and prevention of bleeding from esophageal varices in patients with portal vein thrombosis generally corresponds to that for intrahepatic portal hypertension in liver cirrhosis with some additions. Aim. Presentation of the results of clinical observation of an open Hassab operation (esophagogastric devascularization without esophageal transection + splenectomy) in a patient with portal vein thrombosis complicated by portal hypertension and esophageal varices, as well as a short literary excursion on this issue.
keywords: liver cirrhosis, portal hypertension, esophageal varices, esophagogastric devascularization, azigoportal disconnection

for references: E.V. Mahiliavets. Clinical case of treatment of a patient with portal hypertension developed as a result of portal vein thrombosis Neotlozhnaya kardiologiya i kardioovaskulyarnye riski [Emergency cardiology and cardiovascular risks], 2020, vol. 4, no. 2, pp. 1030–1036

1. Bosch J., Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int, 2018, vol. 12, Suppl 1, pp. 1-10. doi: 10.1007/s12072-017-9827-9.
2. D’Amico G., De Franchis R. Cooperative Study G. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology, 2003, vol. 38, pp. 599-612.
3. Hernández-Gea V., De Gottardi F., Leebeek F.W.G., Rautou P.-E., Salem R., Garcia-Pagan J.C. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol, 2019, vol. 71, pp. 175-199. doi: 10.1016/j.jhep.2019.02.015.
4. Ageno W., Dentali F., Pomero F. Fenoglio L., Squizzato A., Pagani G., Re R., Bonzini M. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari syndrome. Thromb Haemost, 2017, vol. 117, pp. 794-800. doi.org/10.1160/TH16-10-0781.
5. Seijo S., Plessier A. Noncirrhotic nontumoral portal vein thrombosis. Clinl Liver Dis, 2014, vol. 3, pp. 118-121. doi:10.1002/cld.336.
6. Wani Z.A., Bhat R.A., Bhadoria A.S., Maiwall R. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: need for a new classification. Saudi J Gastroenterol, 2015, vol. 21, pp. 129-138. doi:10.4103/1319-3767.157550.
7. Могилевец, Э.В. Портальная гипертензия при отсутствии цирроза печени (обзор литературы). Журнал Гродненского государственного медицинского университета, 2015, № 1, c. 26-30.
8. Simonetto D.A., Liu M., Kamath P.S. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clin Proc., 2019, vol. 94, pp. 714-726. doi: 10.1016/j.mayocp.2018.12.020.
9. Condat B., Pessione F., Hillaire S., Denninger M.H., Guillin M.C., Poliquin M., Hadengue A., Erlinger S., Valla D. Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy. Gastroenterology, 2001, vol. 120, pp. 490-497. doi: 10.1053/gast.2001.21209.
10. Orr D.W., Harrison P.M., Devlin J., Karani J.B., Kane P.A., Heaton N.D., O’Grady J.G., Heneghan M.A. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol, 2007, vol. 5, pp. 80-86. doi: 10.1016/j.cgh.2006.09.030.
11. Ferreira C.N., Seijo S., Plessier A., Silva-Junior G., Turon F., Rautou P.-E., Baiges A., Bureau C., Bosch J., Hernández-Gea V., Valla D., García-Pagan J.-C. Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis. Hepatology, 2016, vol. 63, pp. 1640-1650. doi: 10.1002/hep.28466.
12. Sarin S.K., Gupta N., Jha S.K., Agrawal A., Mishra S.R., Sharma B.C., Kumar A. Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. Gastroenterology, 2010, vol. 139, pp. 1238-1245. doi: 10.1053/j.gastro.2010.06.017.
13. de Franchis R., Baveno V.I.F. Expanding consensus in portal hypertension. Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol, 2015, vol. 63, pp. 743-752. doi: 10.1016/j.jhep.2015.05.022.
14. Voros D., Polydorou A., Polymeneas G., Vassiliou I., Melemeni A., Chondrogiannis K., Arapoglou V., Fragulidis G.P. Long-term results with the modified Sugiura procedure for the management of variceal bleeding: standing the test of time in the treatment of bleeding esophageal varices. World J Surg, 2012, vol. 36, pp. 659-666.
15. Klavien P.A., Sarr M.G., Fong U. Atlas hirurgii verhnih otdelov zheludochno-kishechnogo trakta, pecheni, podzheludochnoj zhelezy i zhelchnyh putej [Atlas of surgery of the upper gastrointestinal tract, liver, pancreas and biliary tract]. Moscow: Izdatel’stvo Panfilova BINOM, 2009 (in Russian).
16. Plessier A., Darwish-Murad S., Hernandez-Guerra M., Consigny Y., Fabris F., Trebicka J., Heller J., Morard I., Lasser L., Langlet P. et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology, 2010, vol. 51, pp. 210-218. doi: 10.1002/hep.23259.
17. Holster I.L., Kuipers E.J., van Buuren H.R., Spaander M.C.W., Tjwa E.T.T.L. Self-expandable metal stents as definitive treatment for esophageal variceal bleeding. Endoscopy, 2013, vol. 45, pp. 485-488. doi: 10.1055/s-0032-1326227.
18. Association E. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol, 2016, vol. 64, pp. 179-202.
19. Mínguez B., García-Pagán J.C., Bosch J., Turnes J., Alonso J., Rovira A., Córdoba J. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology, 2006, vol. 43, pp. 707-714. doi: 10.1002/hep.21126.
20. Haciyanli M., Genc H., Halici H., Kumkumoglu Y., Gur O.S., Ozturk T. Results of modified Sugiura operation in variceal bleeding in cirrhotic and noncirrhotic patients. Hepatogastroenterology, 2003, vol. 50, no 51, pp. 784-788.
21. Irawan H., Mulyawan I.M. Combination of modified Sugiura technique and proximal splenorenal shunt for the management of portal vein thrombosis in noncirrhotic portal hypertension. Clin Exp Gastroenterol, 2019, vol. 12, pp. 149-156. doi: 10.2147/CEG.S188200.
22. Goyal N., Singhal D., Gupta S., Soin A.S., Nundy S. Transabdominal gastroesophageal devascularization without transection for bleeding varices: results and indicators of prognosis. J Gastroenterol Hepatol, 2007, vol. 22, pp. 47-50. doi:10.1111/j.1440-1746.2006.04330.
23. Leng X.S. Current status and perspectives in the management of portal hypertension. Chin J Bases Clin General Surg, 2013, vol. 20, pp. 1-3.
24. de Magalhães K.L., Negro-Dellacqua M., Dos Santos V.E.F.A., de Castro C.M.M.B. Post-splenectomy infections in chronic schistosomiasis as a consequence of bacterial translocation. Rev Soc Bras Med Trop, 2015, vol. 48, pp. 314-320. doi: 10.1590/0037-8682-0042-2015.
25. Leone G., Pizzigallo E. Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases. Mediterr J Hematol Infect Dis, 2015, vol. 7, pp. e2015057.
26. Cheng Z., Li J.W., Chen J. Fan Y-d., Guo P., Zheng S-g. Therapeutic effects of laparoscopic splenectomy and esophagogastric devascularization on liver cirrhosis and portal hypertension in 204 cases. J Laparoendosc Adv Surg Tech A, 2014, vol. 24, pp. 612-616. doi: 10.1089/lap.2014.0036.
27. Klinger C., Riecken B., Schmidt A., De Gottardi A., Meier B., Bosch J., Caca K. Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis. Z Gastroenterol, 2018, vol. 56, no. 3, pp. 221-237. doi: 10.1055/s-0043-121348.
28. Smalberg J.H., Spaander M.V.C.W., Jie K.-S.G., Pattynama P.M.T., van Buuren H.R., van den Berg B., Janssen H.L.A., Leebeek F.W.G. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost, 2008, vol. 100, pp. 1084-1088.
29. Rosenqvist K., Eriksson L.-G., Rorsman F., Sangfelt P., Nyman R. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver. Acta Radiol, 2016, vol. 57, pp. 572-579. doi: 10.1177/0284185115595060.
30. Nuzzo A., Maggiori L., Ronot M., Becq A., Plessier A., Gault N., Joly F., Castier Y., Vilgrain V., Paugam C., Panis Y., Bouhnik Y., Cazals-Hatem D., Corcos O. Predictive factors of intestinal necrosis in acute mesenteric ischemia: prospective study from an intestinal stroke center. Am J Gastroenterol, 2017, vol. 112, pp. 597-605. doi: 10.1038/ajg.2017.38.
31. Hmoud B., Singal A.K., Kamath P.S. Mesenteric venous thrombosis. J Clin Exp Hepatol, 2014, vol. 4, pp. 257-263. doi: 10.1016/j.jceh.2014.03.052.
File extension: pdf (292.58 KB)